Home/Filings/4/0001213900-24-026818
4//SEC Filing

Carter Charles Ross 4

Accession 0001213900-24-026818

CIK 0001870404other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 9:26 PM ET

Size

5.6 KB

Accession

0001213900-24-026818

Insider Transaction Report

Form 4
Period: 2024-03-25
Carter Charles Ross
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-25+395,387395,387 total
    Exercise: $1.77Exp: 2034-03-24Common Stock (395,387 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in forty-eight (48) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

CERO THERAPEUTICS HOLDINGS, INC.

CIK 0001870404

Entity typeother

Related Parties

1
  • filerCIK 0001779359

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 9:26 PM ET
Size
5.6 KB